Resources

At the 2013 Women Deliver Conference in Kuala Lumpur, Elizabeth Abu Haydar—a PATH public health specialist—presented an overview of PATH’s work activities on the non-pneumatic antishock garment in a workshop discussing local manufacturing and logistics.

This issue of Directions in Global Health features work by OneWorld Health, PATH’s drug development program, to lead development of innovative methods to enhance the supply of artemisinin, a key ingredient in malaria treatments. It includes a commentary by Dr. Ponni Subbiah, who directs PATH’s drug development efforts. Other articles cover work to improve cervical cancer screening, protect infants from respiratory syncytial virus, increase access to family planning, and strengthen and expand use of human milk banking.

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

This qualitative study investigated the perceptions and policy implications of home and self-injection of Sayana® Press in Ethiopia’s Oromia region. Sayana® Press is the subcutaneous formulation of the three-month injectable depot medroxyprogesterone acetate (DMPA) in the Uniject™ injection system. This study did not include actual product use in humans.

This paper is the first in a series that will demonstrate how nonprofit product development organizations work to advance research and development for poverty-related and neglected diseases and conditions in low- and middle-income countries. This series is meant to inform global policy and financing debates, including but not limited to discussions on the recommendations outlined in the 2012 report from the WHO Consultative Expert Working Group on research and development.